Grape King Bio Ltd (TPE:1707)
Taiwan
· Delayed Price · Currency is TWD 142.00
-0.50 (-0.35%)
Apr 2, 2025, 10:36 AM CST
Grape King Bio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 11,160 | 10,635 | 10,391 | 9,798 | 9,168 | Upgrade
|
| Revenue Growth (YoY) | 4.93% | 2.35% | 6.05% | 6.87% | -0.77% | Upgrade
|
| Cost of Revenue | 2,502 | 2,099 | 1,909 | 1,942 | 1,631 | Upgrade
|
| Gross Profit | 8,658 | 8,536 | 8,482 | 7,856 | 7,537 | Upgrade
|
| Selling, General & Admin | 5,866 | 5,747 | 5,639 | 5,252 | 4,979 | Upgrade
|
| Research & Development | 291.91 | 289.55 | 289.88 | 292.23 | 252.86 | Upgrade
|
| Other Operating Expenses | 0.02 | 2.48 | 1.1 | 0.57 | -0.05 | Upgrade
|
| Operating Expenses | 6,158 | 6,039 | 5,930 | 5,544 | 5,232 | Upgrade
|
| Operating Income | 2,500 | 2,497 | 2,552 | 2,312 | 2,305 | Upgrade
|
| Interest Expense | -2.95 | -2.45 | -2.29 | -3.93 | -14.24 | Upgrade
|
| Interest & Investment Income | 49.97 | 47.6 | 19.92 | 6.29 | 4.63 | Upgrade
|
| Earnings From Equity Investments | 22.24 | 19.87 | 10.82 | 2.23 | 1.68 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.38 | 0.67 | 11.63 | -2.24 | -6.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 94.13 | 98.9 | 94.1 | 99.35 | 87.95 | Upgrade
|
| EBT Excluding Unusual Items | 2,671 | 2,661 | 2,686 | 2,413 | 2,379 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.9 | 0.42 | -1.91 | 0.8 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.62 | -1.07 | 3.76 | 0.82 | -0.46 | Upgrade
|
| Other Unusual Items | 1.18 | 0.01 | 0.11 | - | - | Upgrade
|
| Pretax Income | 2,673 | 2,661 | 2,688 | 2,415 | 2,378 | Upgrade
|
| Income Tax Expense | 502.15 | 519.11 | 518.19 | 466.92 | 483.1 | Upgrade
|
| Earnings From Continuing Operations | 2,171 | 2,142 | 2,170 | 1,948 | 1,895 | Upgrade
|
| Minority Interest in Earnings | -722.85 | -688.78 | -712.58 | -647.57 | -623.07 | Upgrade
|
| Net Income | 1,448 | 1,453 | 1,457 | 1,300 | 1,272 | Upgrade
|
| Net Income to Common | 1,448 | 1,453 | 1,457 | 1,300 | 1,272 | Upgrade
|
| Net Income Growth | -0.30% | -0.30% | 12.05% | 2.23% | -2.83% | Upgrade
|
| Shares Outstanding (Basic) | 148 | 148 | 148 | 148 | 136 | Upgrade
|
| Shares Outstanding (Diluted) | 149 | 149 | 149 | 148 | 137 | Upgrade
|
| Shares Change (YoY) | 0.03% | 0.04% | 0.45% | 8.41% | 0.21% | Upgrade
|
| EPS (Basic) | 9.78 | 9.81 | 9.84 | 8.81 | 9.34 | Upgrade
|
| EPS (Diluted) | 9.71 | 9.74 | 9.78 | 8.76 | 9.29 | Upgrade
|
| EPS Growth | -0.31% | -0.41% | 11.64% | -5.71% | -3.03% | Upgrade
|
| Free Cash Flow | 1,249 | 1,932 | 2,504 | 2,267 | 1,505 | Upgrade
|
| Free Cash Flow Per Share | 8.38 | 12.96 | 16.80 | 15.28 | 11.00 | Upgrade
|
| Dividend Per Share | 6.900 | 6.900 | 6.900 | 6.100 | 6.400 | Upgrade
|
| Dividend Growth | - | - | 13.11% | -4.69% | -1.54% | Upgrade
|
| Gross Margin | 77.58% | 80.26% | 81.63% | 80.18% | 82.20% | Upgrade
|
| Operating Margin | 22.40% | 23.47% | 24.56% | 23.59% | 25.14% | Upgrade
|
| Profit Margin | 12.98% | 13.66% | 14.02% | 13.27% | 13.87% | Upgrade
|
| Free Cash Flow Margin | 11.19% | 18.17% | 24.09% | 23.14% | 16.42% | Upgrade
|
| EBITDA | 2,933 | 2,885 | 2,936 | 2,679 | 2,658 | Upgrade
|
| EBITDA Margin | 26.28% | 27.13% | 28.26% | 27.34% | 28.99% | Upgrade
|
| D&A For EBITDA | 433.33 | 388.3 | 384.63 | 367.68 | 352.76 | Upgrade
|
| EBIT | 2,500 | 2,497 | 2,552 | 2,312 | 2,305 | Upgrade
|
| EBIT Margin | 22.40% | 23.47% | 24.56% | 23.59% | 25.14% | Upgrade
|
| Effective Tax Rate | 18.78% | 19.51% | 19.28% | 19.34% | 20.31% | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.